Children with Difficult Asthma: A Practical Approach

REFERENCES

• National Asthma Education and Prevention Program. Expert Panel Report II: Guidelines for the Diagnosis and Management of Asthma. National Institutes of Health, National Heart, Lung, and Blood Institute, Bethesda, MD 1997
   Google Scholar
• The British Thoracic Society, the National Asthma Campaign, the Royal College of Physicians of London in Association with the General Practitioner in Asthma Group, the British Association of Accident and Emergency Medicine, the British Paediatric Respiratory Society, and the Royal College of Paediatrics and Child Health. The British Guidelines on Asthma Management 1995 Review and Position Statement. Thorax 1997; 52: S1–S21
   Web of Science ®Google Scholar
• ERS Taskforce on Difficult/Therapy-Resistant Asthma. Difficult/Therapy-Resistant Asthma: The Need for an Integrated Approach to Define Clinical Phenotypes, Evaluate Risk Factors, Understand Pathophysiology and Find Novel Therapies. Eur. Respir. J. 1999; 13: 1198–1208
   PubMed Web of Science ®Google Scholar
• Buist S. A. Cost-Effectiveness of Asthma Management Strategies. Eur. Resp. Rev. 1995; 5: 292–294
   Google Scholar
• Sly P. D. Lung Function. Childhood Asthma and Other Wheezing Disorders, M. Silverman. Chapman and Hall Medical, London 1995; 115–139
   Google Scholar
• Reversibility of Airflow Obstruction: FEV1 vs Peak Flow. Lancet 1992; 340: 85–86
   PubMed Web of Science ®Google Scholar
• Hutchinson A. A., Erben A., McLennan L. A., et al. Intra-Subject Variability of Pulmonary Function Testing in Healthy Children. Thorax 1981; 36: 370–377
   Google Scholar
• Waalkens H. J., Merkus P. J.F.M., van Essen-Zandvliet E. E.M., et al. Assessment of Bronchodilator Response in Children with Asthma. Eur. Resp. J. 1993; 6: 645–651
   PubMed Web of Science ®Google Scholar
• Payne D. N.R., Lincoln C., Bush A. Right-Sided Aortic Arch in Children with Persistent Respiratory Symptoms. Br. Med. J., in press
   Google Scholar
• Peters F. T.M., Kleibeuker J. H., Postma D. S. Gastric Asthma: A Pathophysiological Entity?. Scand. J. Gastroenterol. 1997; 33(Suppl. 225)19–23
   Google Scholar
• Ekstrom T., Tibbling L. Gastro-Oesophageal Reflux and Triggering of Bronchial Asthma: A Negative Report. Eur. J. Resp. Dis. 1987; 71: 177–180
   PubMedGoogle Scholar
• Wilson N. M., Charette L., Thomson A. H., et al. Gastro-Oesophageal Reflux and Childhood Asthma: The Acid Test. Thorax 1985; 40: 592–570
   PubMed Web of Science ®Google Scholar
• Hampton F. J., MacFayden U. M., Beardsmore C. S., et al. Gastro-Oesophageal Reflux and Respiratory Function in Infants with Respiratory Symptoms. Arch. Dis. Child. 1991; 66: 848–853
   Google Scholar
• Washington N., Spensley P. J., Smith C. A., et al. Dual pH Probe Monitoring Versus Single pH Probe Monitoring in Infants on Milk Feeds: The Impact on Diagnosis. Arch. Dis. Child. 1999; 81: 309–312
   PubMed Web of Science ®Google Scholar
• Malfgroot A., Giocoli M., Dab I. Respiratory Complications of Gastro-Oesophageal Reflux in Children: Asthma Versus Recurrent Infections. Diseases of the Esophagus, Vol II: Benign Diseases, A. G. Little, M. K. Ferguson, D. B. Skinner. Futura Publishing Company: location. 1990; 127–137
   Google Scholar
• Field S. K., Gelfand G. A., McFadden S. D. The Effects of Anti-Reflux Surgery on Asthmatics with Gastroesophageal Reflux. Chest 1999; 116: 766–774
   PubMed Web of Science ®Google Scholar
• Wood R. P., Milgrom H. Vocal Cord Dysfunction. J. Allergy Clin. Immunol. 1996; 98: 481–485
   PubMed Web of Science ®Google Scholar
• Goldman J., Muers M. Vocal Cord Dysfunction and Wheezing. Thorax 1991; 46: 401–404
   PubMed Web of Science ®Google Scholar
• Crowley S., Goldberg D., Argent A., et al. Discordant Noises in Children with Asthma. Clinical Child Psychology and Psychiatry 1998; 3: 613–619
   Google Scholar
• Newman K. B., Mason U. G., Schmaling K. B. Clinical Features of Vocal Cord Dysfunction. Am. J. Resp. Crit. Care Med. 1995; 152: 1382–1386
   PubMed Web of Science ®Google Scholar
• Balfour-Lynn I. M. Difficult Asthma: Beyond the Guidelines. Arch. Dis. Child. 1999; 80: 201–206
   Google Scholar
• Cockcroft D. W., Swystun V. A. Asthma Control Versus Asthma Severity. J. Allergy Clin. Immunol. 1996; 98: 1016–1018
   PubMed Web of Science ®Google Scholar
• Verschelden P., Cartier A., L'Archeveque J., et al. Compliance with and Accuracy of Daily Self-Assessment of Peak Expiratory Flows in Asthmatic Subjects over a Three Month Period. Eur. Respir. J. 1996; 9: 880–885
   PubMed Web of Science ®Google Scholar
• Redline S., Wright E. C., Kattan M., et al. Short-Term Compliance with Peak-Flow Monitoring: Results from a Study of Inner City Children with Asthma. Ped. Pulmonol. 1996; 21: 203–210
   PubMed Web of Science ®Google Scholar
• Bijl-Hofland I. D., Cloosterman S. G.M., Folgering H. T.M., et al. Relation of the Perception of Airway Obstruction to the Severity of Asthma. Thorax 1999; 54: 15–19
   PubMed Web of Science ®Google Scholar
• Nguyen B.-P., Wilson S. R., German D. F. Patients' Perceptions Compared with Objective Ratings of Asthma Severity. Ann. Allergy Asthma Immunol. 1996; 77: 209–215
   PubMed Web of Science ®Google Scholar
• Bisgaard H. Delivery of Inhaled Medication to Children. J. Asthma 1997; 34: 443–467
   PubMed Web of Science ®Google Scholar
• Pedersen S., O'Byrne P. A Comparison of the Efficacy and Safety of Inhaled Corticosteroids in Asthma. Allergy 1997; 52(Suppl. 52)1–34
   Google Scholar
• Chylack L. T. Cataracts and Inhaled Corticosteroids. N. Engl. J. Med. 1997; 337: 47–48
   Google Scholar
• Meijer R. J., Kerstjens H. A.M., Arends L. R., et al. Effects of Inhaled Fluticasone and Oral Prednisolone on Clinical and Inflammatory Parameters in Patients with Asthma. Thorax 1999; 54: 894–899
   PubMed Web of Science ®Google Scholar
• Leung D. Y.M., Szefler S. J. New Insights into Steroid Resistant Asthma. Pediatr. Allergy Immunol. 1998; 9: 3–12
   PubMed Web of Science ®Google Scholar
• Payne D. N.R., Hubbard M., McKenzie S. A. Corticosteroid Unresponsiveness in Asthma: Primary or Acquired?. Pediatr. Pulmonol. 1998; 25: 59–61
   Google Scholar
• Custovic A., Woodcock A. Allergen Avoidance. Br. J. Hosp. Med. 1996; 56: 409–412
   Google Scholar
• Eggleston P. A., Wood R. A., Rand C., et al. Removal of Cockroach Allergen from Inner City Homes. J. Allergy Clin. Immunol. 1999; 104: 842–846
   PubMed Web of Science ®Google Scholar
• Wood R. A., Chapman M. D., Adkinson N. F., et al. The Effect of Cat Removal on Allergen Content in Household-Dust Samples. J. Allergy Clin. Immunol. 1989; 83: 730–734
   PubMed Web of Science ®Google Scholar
• Ronchetti R., Macri F., Ciofetta G., et al. Increased Serum Immunoglobulin E and Increased Prevalence of Eosinophilia in Nine Year Old Children of Smoking Parents. J. Allergy Clin. Immunol. 1990; 86: 400–407
   PubMed Web of Science ®Google Scholar
• Ronchetti R., Bonci E., Cutrera R., et al. Enhanced Allergic Sensitisation Related to Parental Smoking. Arch. Dis. Child. 1992; 67: 496–500
   PubMedGoogle Scholar
• Martinez F., Antognoni G., Macri F., et al. Parental Smoking Enhances Bronchial Responsiveness in Nine Year Old Children. Am. Rev. Resp. Dis. 1988; 138: 518–523
   PubMed Web of Science ®Google Scholar
• Murray A. B., Morrison B. J. The Effect of Cigarette Smoke from Mother on Bronchial Responsiveness and Severity of Symptoms in Children with Asthma. J. Allergy Clin. Immunol. 1986; 77: 575–581
   PubMed Web of Science ®Google Scholar
• Irvine L., Crombie I. K., Clark R. A., et al. Advising Parents of Asthmatic Children on Passive Smoking: Randomised Controlled Trial. Br. Med. J. 1999; 318: 1456–1459
   PubMed Web of Science ®Google Scholar
• Jonasson G., Carlsen K.-H., Sodal A., et al. Patient Compliance in a Clinical Trial with Inhaled Budesonide in Children with Mild Asthma. Eur. Respir. J. 1999; 14: 150–154
   PubMed Web of Science ®Google Scholar
• Milgrom H., Bender B., Ackerson L., et al. Noncompliance and Treatment Failure in Children with Asthma. J. Allergy Clin. Immunol. 1996; 98: 1051–1057
   PubMed Web of Science ®Google Scholar
• Tashkin D. P. Microelectronic Adherence Monitors for Metered-Dose Inhalers: Who Monitors the Monitors?. J. Allergy Clin. Immunol. 1999; 104: 22–24
   PubMed Web of Science ®Google Scholar
• Koocher G., McGrath M., Gudas L. Typologies of Non-Adherence in Cystic Fibrosis. J. Dev. Behav. Paediatr. 1990; 11: 353–358
   PubMed Web of Science ®Google Scholar
• Richards D. G., Mein E. A., Nelson C. D. Chiropractic Manipulation for Childhood Asthma. N. Engl. J. Med. 1999; 340: 391–392
   Google Scholar
• Lane D. J., Lane T. V. Alternative and Complementary Medicine for Asthma. Thorax 1991; 46: 787–797
   PubMedGoogle Scholar
• Bowler S. D., Green A., Mitchell C. A. Buteyko Breathing Techniques in Asthma: A Blinded Randomised Controlled Trial. Med. J. Aust. 1998; 169: 575–578
   PubMed Web of Science ®Google Scholar
• Lask B. Psychological Factors. Childhood Asthma and Other Wheezing Disorders, M. Silverman. Chapman and Hall Medical, London 1995; 421–428
   Google Scholar
• Lask B. Psychological Treatments for Childhood Asthma. Arch. Dis. Child. 1992; 67: 891
   PubMedGoogle Scholar
• Piacentini G. L., Bodini A., Costella S., et al. Exhaled Nitric Oxide and Sputum Eosinophil Markers of Inflammation in Asthmatic Children. Eur. Respir. J. 1999; 13: 1386–1390
   PubMed Web of Science ®Google Scholar
• Mattes J., Storm van's Gravesande K., Reining U., et al. Nitric Oxide in Exhaled Air is Correlated with Markers of Eosinophilic Airway Inflammation in Corticosteroid-Dependent Childhood Asthma. Eur. Respir. J. 1999; 13: 1391–1395
   PubMed Web of Science ®Google Scholar
• Byrnes C. A., Dinarevic S., Shinebourne E. A., et al. Exhaled Nitric Oxide Measurements in Normal and Asthmatic Children. Ped. Pulmonol. 1997; 24: 312–318
   PubMed Web of Science ®Google Scholar
• Kharitonov S. A., Yates D. H., Robbins R. A., et al. Increased Nitric Oxide in Exhaled Air of Asthmatic Patients. Lancet 1994; 343: 133–135
   PubMed Web of Science ®Google Scholar
• Kharitinov S. A., Yates D. H., Chung K. F., et al. Changes in the Dose of Inhaled Steroid Affects Exhaled Nitric Oxide Levels in Asthmatic Patients. Eur. Respir. J. 1996; 9: 196–201
   Google Scholar
• Stirling R. G., Kharitonov S. A., Campbell D., et al. Increase in Exhaled Nitric Oxide Levels in Patients with Difficult Asthma and Correlation with Symptoms and Disease Severity Despite Treatment with Oral and Inhaled Corticosteroids. Thorax 1998; 53: 1030–1034
   PubMed Web of Science ®Google Scholar
• Wenzel S. E., Szefler S. J., Leung D. Y.M., et al. Bronchoscopic Evaluation of Severe Asthma: Persistent Inflammation Associated with High Dose Glucocorticoids. Am. J. Respir. Crit. Care Med. 1997; 156: 737–743
   PubMed Web of Science ®Google Scholar
• Vrugt B., Wilson S., Underwood J., et al. Mucosal Inflammation in Severe Glucocorticoid Dependent Asthma. Eur. Respir. J. 1999; 13: 1245–1252
   Google Scholar
• Wenzel S. E., Schwartz L. B., Langmack E. L., et al. Evidence That Severe Asthma Can Be Divided Pathologically into Two Inflammatory Subtypes with Distinct Physiologic and Clinical Characteristics. Am. J. Respir. Crit. Care Med. 1999; 160: 1001–1008
   PubMed Web of Science ®Google Scholar
• Pavord I. D., Brightling C. E., Woltmann G., et al. Non-Eosinophilic Corticosteroid Unresponsive Asthma. Lancet 1999; 353: 2213–2214
   PubMed Web of Science ®Google Scholar
• Hoskins G., McCowan C., Neville R. G., et al. Risk Factors and Costs Associated with an Asthma Attack. Thorax 2000; 55: 19–24
   PubMed Web of Science ®Google Scholar
• Llangovan P., Pedersen S., Godfrey S., et al. Treatment of Severe Steroid Dependent Preschool Asthma with Nebulised Budesonide Suspension. Arch. Dis. Child. 1993; 68: 356–359
   Google Scholar
• Bisgaard H., Nikander K., Munch E. Comparative Study of Budesonide as a Nebulized Suspension vs Pressurized Metered-Dose Inhaler in Adult Asthmatics. Resp. Med. 1998; 92: 44–49
   PubMed Web of Science ®Google Scholar
• Higenbottam T. W., Clark R. A., Luksza A. R., et al. The Role of Nebulised Budesonide in Permitting a Reduction in the Dose of Oral Steroid in Persistent Severe Asthma. Eur. J. Clin. Res. 1994; 5: 1–10
   Google Scholar
• Westbroek J., Saarelainen S., Laher M., et al. Oral Steroid-Sparing Effect of Two Doses of Nebulised Fluticasone Propionate and Placebo in Patients with Severe Chronic Asthma. Respir. Med. 1999; 93: 689–699
   Google Scholar
• Horwitz R. J., McGill K. A., Busse W. W. The Role of Leukotriene Modifiers in the Treatment of Asthma. Am. J. Resp. Crit. Care Med. 1998; 157: 1363–1371
   PubMed Web of Science ®Google Scholar
• Krawiec M. E., Wenzel S. E. Use of Leukotriene Antagonists in Childhood Asthma. Curr. Opin. Pediatr. 1999; 11: 540–547
   PubMedGoogle Scholar
• Knorr B., Matz J., Bernstein J. A., et al. Montelukast for Chronic Asthma in 6- to 14-Year-Old Children: A Randomized, Double-Blind Trial. Pediatric Montelukast Study Group. JAMA 1998; 279: 1181–1186
   PubMed Web of Science ®Google Scholar
• Kemp J. P., Dockhorn R. J., Shapiro G. G., et al. Montelukast Once Daily Inhibits Exercise-Induced Bronchoconstriction in 6–14 Year Old Children with Asthma. J. Pediatr. 1998; 133: 424–428
   PubMed Web of Science ®Google Scholar
• Adkins J. C., Brogden R. N. Zafirlukast: A Review of Its Pharmacology and Therapeutic Potential in the Management of Asthma. Drugs 1998; 55: 121–144
   PubMed Web of Science ®Google Scholar
• Pearlman D. S., Ostrom N. K., Bronsky E. A., et al. The Leukotriene D4-Receptor Antagonist Zafirlukast Attenuates Exercise-Induced Bronchoconstriction in Children. J. Pediatr. 1999; 134: 273–279
   PubMed Web of Science ®Google Scholar
• Lofdahl C.-G., Reis T. F., Leff J. A., et al. Randomised, Placebo Controlled Trial of Effect of a Leukotriene Receptor Antagonist, Montelukast, on Tapering Inhaled Corticosteroids in Asthmatic Patients. Br. Med. J. 1999; 319: 87–90
   PubMed Web of Science ®Google Scholar
• Alexander A. G., Barnes N. C., Kay A. B. Trial of Cyclosporin in Corticosteroid-Dependent Chronic Severe Asthma. Lancet 1992; 339: 324–328
   PubMed Web of Science ®Google Scholar
• Lock S. H., Kay A. B., Barnes N. C. Double Blind Placebo Controlled Study of Cyclosporin A as a Corticosteroid-Sparing Agent in Corticosteroid-Dependent Asthma. Am. J. Resp. Crit. Care Med. 1996; 153: 509–514
   PubMed Web of Science ®Google Scholar
• Coren M. E., Rosenthal M., Bush A. The Use of Cyclosporin in Corticosteroid Dependent Asthma. Arch. Dis. Child. 1997; 77: 522–523
   Google Scholar
• O'Driscoll B. R.C., Ruffles S. P., Ayres J. G., et al. Long Term Treatment of Severe Asthma with Subcutaneous Terbutaline. Br. J. Dis. Chest 1988; 82: 360–367
   PubMedGoogle Scholar
• Cluzel M., Bousquet J., Daures J. P., et al. Ambulatory Long-Term Subcutaneous Salbutamol Infusion in Chronic Servere Asthma. J. Allergy Clin. Immunol. 1990; 85: 599–605
   Google Scholar
• Brémont F., Moisan V., Dutau G. Continuous Subcutaneous Infusion of Beta2-Agonists in Infantile Asthma. Peditar. Pulmonol. 1992; 12: 81–83
   PubMed Web of Science ®Google Scholar
• Ayres J. G., Miles J. F., Barnes P. J. Brittle Asthma. Thorax 1998; 53: 315–321
   PubMed Web of Science ®Google Scholar
• Mazer B. D., Gelfand E. W. An Open-Label Study of High-Dose Intravenous Immunoglobulin in Severe Childhood Asthma. J. Allergy Clin. Immunol. 1991; 87: 976–983
   PubMed Web of Science ®Google Scholar
• Jakobsson T., Croner S., Kjellman N. I., et al. Slight Steroid-Sparing Effect of Intravenous Immunoglobulin in Children and Adolescents with Moderately Severe Bronchial Asthma. Allergy 1994; 49: 413–420
   Google Scholar
• Spahn J. D., Leung D. Y., Chan M. T., et al. Mechanisms of Glucocorticoid Reduction in Asthmatic Subjects Treated with Intravenous Immunoglobulin. J. Allergy Clin. Immunol. 1999; 103: 421–426
   Google Scholar
• Sigman K., Ghibu F., Sommerville W., et al. Intravenous Immunoglobulin Inhibits IgE Production in Human B Lymphocytes. J. Allergy Clin. Immunol. 1998; 102(3)421–427
   Google Scholar
• Vrugt B., Wilson S., van Velzen E., et al. Effects of High Dose Intravenous Immunoglobulin in Two Severe Corticosteroid Insensitive Asthmatic Children. Thorax 1997; 52: 662–664
   Google Scholar
• Niggemann B., Leupold W., Schuster A., et al. Prospective, Double-Blind, Placebo-Controlled, Multicentre Study on the Effect of High-Dose, Intravenous Immunoglobulin in Children and Adolescents with Severe Bronchial Asthma. Clin. Exp. Allergy 1998; 28: 205–210
   Google Scholar
• Salmun L. M., Barlau I., Wolf H. M., et al. Effect of Intravenous Immunoglobulin on Steroid Consumption in Patients with Severe Asthma: A Double-Blind, Placebo-Controlled, Randomised Trial. J. Allergy Clin. Immunol. 1999; 103: 810–815
   PubMed Web of Science ®Google Scholar
• Kishimaya J. L., Valacer D., Cunningham-Rundles C., et al. A Multicenter, Randomised, Double-Blind, Placebo-Controlled Trial of Intravenous Immunoglobulin for Oral Corticosteroid-Dependent Asthma. Clin. Immunol. 1999; 91(2)126–133
   Google Scholar
• Marin M. G. Low-Dose Methotrexate Spares Steroid Usage in Steroid-Dependent Asthmatic Patients: A Meta-Analysis. Chest 1997; 112: 29–33
   PubMed Web of Science ®Google Scholar
• Aaron S. D., Dales R. E., Pham B. Management of Steroid-Dependent Asthma with Methotrexate: A Meta-Analysis of Randomised Clinical Trials. Respir. Med. 1998; 92: 1059–1065
   PubMed Web of Science ®Google Scholar
• Stempel D. A., Lammert J., Mullarkey M. F. Use of Methotrexate in the Treatment of Steroid-Dependent Adolescent Asthmatics. Ann. Allergy 1991; 67: 346–348
   Google Scholar
• Guss S., Portnoy J. Methotrexate Treatment of Severe Asthma in Children. Pediatrics 1992; 89: 635–639
   Google Scholar
• Sole D., Costa-Carvalho B. T., Soares F. J., et al. Methotrexate in the Treatment of Corticodependent Asthmatic Children. J. Investing. Allergol. Clin. Immunol. 1996; 6: 126–130
   Google Scholar
• Norman P. S. Is There a Role for Immunotherapy in the Treatment of Asthma?. Yes. Am. J. Respir. Crit. Care Med. 1996; 154: 1225–1226
   Google Scholar
• Barnes P. J. Is There a Role for Immunotherapy in the Treatment of Asthma?. No. Am. J. Respir. Crit. Care Med. 1996; 154: 1227–1228
   Google Scholar
• Abramson M. J., Puy R. M., Weiner J. M. Is Allergen Immunotherapy Effective in Asthma? A Meta-Analysis of Randomised Controlled Trials. Am. J. Respir. Crit. Care Med. 1995; 151: 969–974
   PubMed Web of Science ®Google Scholar
• Bousquet J., Michel F.-B. Specific Immunotherapy in Asthma: Is It Effective?. J. Allergy Clin. Immunol. 1994; 94: 1–11
   PubMed Web of Science ®Google Scholar
• Creticos P. S., Reed C. E., Norman P. S., et al. Ragweed Immunotherapy in Adult Asthma. N. Engl. J. Med. 1996; 334: 501–506
   PubMed Web of Science ®Google Scholar
• Adkinson N. F., Eggleston P. A., Eney D., et al. A Controlled Trial of Immunotherapy for Asthma in Allergic Children. N. Engl. J. Med. 1997; 336: 324–331
   PubMed Web of Science ®Google Scholar
• Muranaka M., Nakajima K., Suzuki S. Bronchial Responsiveness to Acetylcholine in Patients with Bronchial Asthma After Long-Term Treatment with Gold Salt. J. Allergy Clin. Immunol. 1981; 67: 350–356
   PubMed Web of Science ®Google Scholar
• Muranaka M., Miyamoto T., Shida T., et al. Gold Salt in the Treatment of Bronchial Asthma: A Double Blind Study. Ann. Allergy 1978; 40: 132–137
   Google Scholar
• Nierop G., Gijzel W. P., Bel E. H., et al. Auranofin in the Treatment of Steroid Dependent Asthma: A Double Blind Study. Thorax 1992; 47: 349–354
   Google Scholar
• Bernstein I. L., Bernstein D. I., Dubb J. W., et al. A Placebo-Controlled Multicenter Study of Auranofin in the Treatment of Patients with Corticosteroid-Dependent Asthma. J. Allergy Clin. Immunol. 1996; 98: 317–324
   Google Scholar
• Ball B. D., Hill M. R., Brenner M., et al. Effect of Low-Dose Troleandomycin on Glucocorticoid Pharmacokinetics and Airway Hyperresponsiveness in Severely Asthmatic Children. Ann. Allergy 1990; 65: 37–45
   PubMedGoogle Scholar
• Zeiger R. S., Schatz M., Sperling W., et al. Efficacy of Troleandomycin in Outpatients with Severe, Corticosteroid-Dependent Asthma. J. Allergy Clin. Immunol. 1980; 66: 438–446
   PubMedGoogle Scholar
• Hahn D. L., Bukstein D., Luskin A., et al. Evidence for Chlamydia Pneumoniae Infection in Steroid-Dependent Asthma. Ann. Allergy Asthma Immunol. 1998; 80: 45–49
   PubMed Web of Science ®Google Scholar
• Berlow B. A., Liebhaber M. I., Dyer Z., et al. The Effect of Dapsone in Steroid Dependent Asthma. J. Allergy Clin. Immunol. 1991; 87: 710–715
   PubMedGoogle Scholar
• Charous B. L. Open Study of Hydroxychloroquine in the Treatment of Severe Symptomatic or Corticosteroid-Dependent Asthma. Ann. Allergy 1990; 65: 53–58
   Google Scholar
• Roberts J. A., Gunneberg A., Elliot J. A., et al. Hydroxy-chloroquine in Steroid Dependent Asthma. Pulm. Pharmacol. 1988; 1: 59–61
   Google Scholar
• Rabinovitch N., Gelfand E. W. New Approaches to the Treatment of Childhood Asthma. Curr. Opin. Pediatr. 1998; 10: 243–249
   Google Scholar
• Milgrom H., Fick R. B., Su J. Q., et al. Treatment of Allergic Asthma with Monoclonal Anti-IgE Antibody. N. Engl. J. Med. 1999; 341: 1966–1973
   PubMed Web of Science ®Google Scholar
• Hatzelmann A., Tenor H., Schudt C. Differential Effects of Non-Selective and Selective Phosphodiesterase Inhibitors on Human Eosinophil Functions. Br. J. Pharmacol. 1995; 114: 821–831
   Google Scholar
• Sullivan P., Bekir S., Jaffar Z., et al. Anti-Inflammatory Effects of Low-Dose Oral Theophylline in Atopic Asthma. Lancet 1994; 343: 1006–1008
   PubMed Web of Science ®Google Scholar
• Barnes P. J., Pederson S., Busse W. W. Efficacy and Safety of Inhaled Corticosteroids: New Developments. Am. J. Respir. Crit. Care Med. 1998; 157: S1–S53
   Google Scholar
• Reiser J., Warner J. O. The Value of Participating in an Asthma Trial. Lancet 1985; 1: 206–207
   PubMed Web of Science ®Google Scholar